The biological role of the Fas/FasL system during tumor formation and progression

被引:117
作者
Reichmann, E [1 ]
机构
[1] Univ Zurich, Childrens Hosp, Dept Pediat Surg, Fetal & Pediat Surg Res Lab, CH-8032 Zurich, Switzerland
关键词
apoptosis; Fas; Fas-ligand; tissue homeostasis; tumor development; anti-cancer therapy;
D O I
10.1016/S1044-579X(02)00017-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The cells of an organism are constantly exposed to conflicting environmental cues that signal cell survival or cell death. Survival signals are delivered by autocrine or paracrine factors that actively suppress a default death pathway. This default death pathway appears to be activated by dedicated death receptors such as Fas, the TRAIL-receptors and other tumor necrosis factor receptor superfamily proteins (TNFR SFPs). Our understanding of how these counteracting receptor systems are modulated during tumorigenesis is only moderate. Nevertheless, there is now broad evidence that susceptibility of tumor cells towards Fas-mediated apoptosis is largely reduced. In addition, tumor cells frequently exhibit de novo expression of Fas-ligand (FasL) which plays a significant role in local tissue destruction, metastatic spread and immune escape of the tumor cells. Restoring the apoptotic potential of cancer cells upon modulating the expression and activity of certain key components of the cell death machinery is an attractive and obvious therapeutic anti-cancer strategy.
引用
收藏
页码:309 / 315
页数:7
相关论文
共 61 条
[51]   FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2 [J].
Sprick, MR ;
Weigand, MA ;
Rieser, E ;
Rauch, CT ;
Juo, P ;
Blenis, J ;
Krammer, PH ;
Walczak, H .
IMMUNITY, 2000, 12 (06) :599-609
[52]   Bcl-xL functions downstream of caspase-8 to inhibit Fas- and tumor necrosis factor receptor 1-induced apoptosis of MCF7 breast carcinoma cells [J].
Srinivasan, A ;
Li, F ;
Wong, A ;
Kodandapani, L ;
Smidt, R ;
Krebs, JF ;
Fritz, LC ;
Wu, JC ;
Tomaselli, KJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (08) :4523-4529
[53]   Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - A mechanism of immune evasion? [J].
Strand, S ;
Hofmann, WJ ;
Hug, H ;
Muller, M ;
Otto, G ;
Strand, D ;
Mariani, SM ;
Stremmel, W ;
Krammer, PH ;
Galle, PR .
NATURE MEDICINE, 1996, 2 (12) :1361-1366
[54]  
SUDA T, 1995, J IMMUNOL, V154, P3806
[55]   MOLECULAR-CLONING AND EXPRESSION OF THE FAS LIGAND, A NOVEL MEMBER OF THE TUMOR-NECROSIS-FACTOR FAMILY [J].
SUDA, T ;
TAKAHASHI, T ;
GOLSTEIN, P ;
NAGATA, S .
CELL, 1993, 75 (06) :1169-1178
[56]   Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site [J].
Takimoto, R ;
El-Deiry, WS .
ONCOGENE, 2000, 19 (14) :1735-1743
[57]   A NOVEL DOMAIN WITHIN THE 55 KD TNF RECEPTOR SIGNALS CELL-DEATH [J].
TARTAGLIA, LA ;
AYRES, TM ;
WONG, GHW ;
GOEDDEL, DV .
CELL, 1993, 74 (05) :845-853
[58]   MONOCLONAL-ANTIBODY - MEDIATED TUMOR-REGRESSION BY INDUCTION OF APOPTOSIS [J].
TRAUTH, BC ;
KLAS, C ;
PETERS, AMJ ;
MATZKU, S ;
MOLLER, P ;
FALK, W ;
DEBATIN, KM ;
KRAMMER, PH .
SCIENCE, 1989, 245 (4915) :301-305
[59]   Tumoricidal activity of tumor necrosis factor related apoptosis-inducing ligand in vivo [J].
Walczak, H ;
Miller, RE ;
Ariail, K ;
Gliniak, B ;
Griffith, TS ;
Kubin, M ;
Chin, W ;
Jones, J ;
Woodward, A ;
Le, T ;
Smith, C ;
Smolak, P ;
Goodwin, RG ;
Rauch, CT ;
Schuh, JCL ;
Lynch, DH .
NATURE MEDICINE, 1999, 5 (02) :157-163
[60]   Autoproteolytic activation of pro-caspases by oligomerization [J].
Yang, XL ;
Chang, HY ;
Baltimore, D .
MOLECULAR CELL, 1998, 1 (02) :319-325